Studies by RAP have a weak efficacy for a medial diagnostic tool. The associated liability with a misdiagnosis is far too high. Neither the patient or the physician will truly trust the app. I had a clinical specialist review RAP's clinical trail results - his response was 'meh'. No hard evidence and a bit of pseudo science saying that you can diagnose something from the sound of a cough.
Good luck.
- Forums
- ASX - By Stock
- PainChek General Discussion
Studies by RAP have a weak efficacy for a medial diagnostic...
-
- There are more pages in this discussion • 11,396 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M |
Open | High | Low | Value | Volume |
3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 497311 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 254838 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 497311 | 0.034 |
5 | 506515 | 0.033 |
2 | 203000 | 0.032 |
3 | 755413 | 0.031 |
7 | 978333 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 254838 | 1 |
0.037 | 39314 | 1 |
0.038 | 243812 | 1 |
0.039 | 16000 | 1 |
0.040 | 100025 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
PCK (ASX) Chart |